Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Cannabidiol in inflammatory bowel diseases: a brief overview.

Esposito G, Filippis DD, Cirillo C, Iuvone T, Capoccia E, Scuderi C, Steardo A, Cuomo R, Steardo L.

Phytother Res. 2013 May;27(5):633-6. doi: 10.1002/ptr.4781. Epub 2012 Jul 20. Review.

PMID:
22815234
2.

Evaluation of new therapies for inflammatory bowel disease.

Carty E, Rampton DS.

Br J Clin Pharmacol. 2003 Oct;56(4):351-61. Review. Erratum in: Br J Clin Pharmacol. 2003 Nov;56(5):584.

3.

Purified Cannabidiol, the main non-psychotropic component of Cannabis sativa, alone, counteracts neuronal apoptosis in experimental multiple sclerosis.

Giacoppo S, Soundara Rajan T, Galuppo M, Pollastro F, Grassi G, Bramanti P, Mazzon E.

Eur Rev Med Pharmacol Sci. 2015 Dec;19(24):4906-19.

4.

The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis.

Jamontt JM, Molleman A, Pertwee RG, Parsons ME.

Br J Pharmacol. 2010 Jun;160(3):712-23. doi: 10.1111/j.1476-5381.2010.00791.x.

5.

Advances in inflammatory bowel diseases in children.

Michail S, Ramsy M, Soliman E.

Minerva Pediatr. 2012 Jun;64(3):257-70. Review.

PMID:
22555319
6.

Efficacy of drugs used in the treatment of IBD and combinations thereof in acute DSS-induced colitis in mice.

Sann H, Erichsen Jv, Hessmann M, Pahl A, Hoffmeyer A.

Life Sci. 2013 Apr 9;92(12):708-18. doi: 10.1016/j.lfs.2013.01.028. Epub 2013 Feb 8.

PMID:
23399699
7.

Cannabis use amongst patients with inflammatory bowel disease.

Lal S, Prasad N, Ryan M, Tangri S, Silverberg MS, Gordon A, Steinhart H.

Eur J Gastroenterol Hepatol. 2011 Oct;23(10):891-6. doi: 10.1097/MEG.0b013e328349bb4c.

PMID:
21795981
8.

Biologic therapy for inflammatory bowel disease.

Ardizzone S, Bianchi Porro G.

Drugs. 2005;65(16):2253-86. Review.

PMID:
16266194
9.

The case for assessing cannabidiol in epilepsy.

Cilio MR, Thiele EA, Devinsky O.

Epilepsia. 2014 Jun;55(6):787-90. doi: 10.1111/epi.12635. Epub 2014 May 22.

10.

Current pharmacotherapy for inflammatory bowel disease.

McKaig BC, Stack WA.

Expert Opin Pharmacother. 1999 Nov;1(1):3-14. Review.

PMID:
11249561
11.

Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders.

Scuderi C, Filippis DD, Iuvone T, Blasio A, Steardo A, Esposito G.

Phytother Res. 2009 May;23(5):597-602. doi: 10.1002/ptr.2625. Review.

PMID:
18844286
12.

Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.

Caprilli R, Angelucci E, Cocco A, Viscido A, Annese V, Ardizzone S, Biancone L, Castiglione F, Cottone M, Meucci G, Paoluzi P, Papi C, Sturniolo GC, Vecchi M.

Dig Liver Dis. 2005 Jun;37(6):407-17. Review.

PMID:
15893279
13.

Optimizing therapy for inflammatory bowel disease.

Robinson M.

Am J Gastroenterol. 1997 Dec;92(12 Suppl):12S-17S. Review.

PMID:
9395347
14.

Anti-inflammatory agents from plants: progress and potential.

Recio MC, Andujar I, Rios JL.

Curr Med Chem. 2012;19(14):2088-103. Review.

PMID:
22414101
15.

New developments in the treatment of inflammatory bowel disease.

Mutlu EA, Farhadi A, Keshavarzian A.

Expert Opin Investig Drugs. 2002 Mar;11(3):365-85. Review.

PMID:
11866666
16.

Intestinal immunomodulation. Role of regulative peptides and promising pharmacological activities.

Motilva V, Talero E, Calvo JR, Villegas I, Alarcón-de-la-Lastra C, Sánchez-Fidalgo S.

Curr Pharm Des. 2008;14(1):71-95. Review.

PMID:
18220820
17.

Botanical Drugs as an Emerging Strategy in Inflammatory Bowel Disease: A Review.

Algieri F, Rodriguez-Nogales A, Rodriguez-Cabezas ME, Risco S, Ocete MA, Galvez J.

Mediators Inflamm. 2015;2015:179616. doi: 10.1155/2015/179616. Epub 2015 Oct 20. Review.

18.

Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis.

De Filippis D, Esposito G, Cirillo C, Cipriano M, De Winter BY, Scuderi C, Sarnelli G, Cuomo R, Steardo L, De Man JG, Iuvone T.

PLoS One. 2011;6(12):e28159. doi: 10.1371/journal.pone.0028159. Epub 2011 Dec 6.

19.

[Biologics in current therapy for inflammatory bowel disease].

Hisamatsu T, Hibi T.

Nihon Rinsho Meneki Gakkai Kaishi. 2009 Jun;32(3):168-79. Review. Japanese.

20.

Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis.

Borrelli F, Aviello G, Romano B, Orlando P, Capasso R, Maiello F, Guadagno F, Petrosino S, Capasso F, Di Marzo V, Izzo AA.

J Mol Med (Berl). 2009 Nov;87(11):1111-21. doi: 10.1007/s00109-009-0512-x. Epub 2009 Aug 20.

PMID:
19690824

Supplemental Content

Support Center